1.Neovascularization in Branch Retinal Vein Occlusion Combined with Arterial Insufficiency.
Yoon Jung LEE ; Joon Hyun KIM ; Myung Kyoo KO
Korean Journal of Ophthalmology 2005;19(1):34-39
The aim of this study is to elucidate the association of neovascularization in branch retinal vein occlusion (BRVO) combined with major arterial insufficiency (MAI), compared with BRVO alone. The authors retrospectively reviewed the charts, color photographs, and fluorescein angiograms of 304 patients (308 eyes) who had BRVO from 1990 to 2002 at Hanyang University hospital. Patients with BRVO combined with MAI and patients with BRVO alone were differentiated by angiographic appearance. Of the 308 eyes, 12 (3.9%) had neovascularization, all of which were in the 56 eyes of the MAI group for which the neovascularization rate was 21.4%. Neovascularization in BRVO was more strongly associated with the non-perfusion caused by MAI, rather than with the extent of the non-perfusion area that originated from retinal capillary obstruction. MAI is considered as a risk factor for neovascularization and hence could be a prognostic factor.
Adult
;
Aged
;
Comparative Study
;
Female
;
Fluorescein Angiography
;
Humans
;
Male
;
Middle Aged
;
Retinal Artery/*physiopathology
;
Retinal Diseases/*complications/physiopathology
;
Retinal Neovascularization/diagnosis/*etiology/physiopathology
;
Retinal Vein Occlusion/*complications/diagnosis/physiopathology
;
Retrospective Studies
2.Characteristic Findings of Optical Coherence Tomography in Retinal Angiomatous Proliferation.
Eun Hae LIM ; Jung Il HAN ; Chul Gu KIM ; Sung Won CHO ; Tae Gon LEE
Korean Journal of Ophthalmology 2013;27(5):351-360
PURPOSE: To identify the unique pathologic findings of retinal angiomatous proliferation (RAP) in optical coherence tomography (OCT). METHODS: Retrospectively, 29 eyes of 25 patients with age-related macular degeneration and complicated RAP were analyzed. All 29 eyes had choroidal neovascularization (CNV) in the area of pigment epithelial detachment (PED) or adjacent to it, which was visible with fluorescein angiography or indocyanine green angiography. Cross-sectional images were obtained by OCT scanning through the CNV lesions. RESULTS: Six distinctive findings of OCT included drusen (100%), inner retinal cyst (80%), outer retinal cyst (68%), fibrovascular PED (84%), serous retinal detachment (40%), and PED (68%). CONCLUSIONS: Through analysis of OCT findings, we revealed six different types of lesions distinctive of RAP which may provide helpful diagnostic information for subsequent treatment and predicting the prognosis of RAP.
Aged
;
Aged, 80 and over
;
Female
;
Follow-Up Studies
;
Humans
;
Macular Degeneration/*complications/diagnosis
;
Male
;
Middle Aged
;
Reproducibility of Results
;
Retina/*pathology
;
Retinal Neovascularization/*diagnosis/etiology
;
Retrospective Studies
;
Severity of Illness Index
;
Tomography, Optical Coherence/*methods
3.ICG-enhanced digital angiography and photocoagulation of choroidal neovascularization in age-related macular degeneration.
Sang Ha KIM ; Dong Eun LEE ; Young Jung PARK
Korean Journal of Ophthalmology 1995;9(1):59-65
Choroidal neovascular membranes are often poorly defined on fluorescein angiography because of fluorescein leakage or blockage of hyperfluorescence by overlying hemorrhage, lipid, turbid fluid, or pigment. Indocyanine green (ICG) is a highly protein-bound dye in the near infrared portion of the spectrum. Therefore, ICG remained in and around the neovascular membrane and enhanced the visualization of certain membranes poorly defined with fluorescein. ICG penetrated through the overlying turbid tissue, and improved the visualization of the underlying choroidal neovascular membrane. Using an infrared angiography system, the authors obtained 21 ICG-angiograms with suspected choroidal neovascularization, and compared them to fluorescein angiograms. In 5 of the 21 eyes, occult choroidal neovascularization was well delineated on the ICG angiograms. In 2 eyes, we were able to detect a well-defined choroidal neovascular membrane underlying a subretinal hemorrhage. In 12 of the 21 eyes with choroidal neovascular membrane, we performed argon-green laser photocoagulation applying the overlay technique of the ICG angiogram to red-free photo or the early fluorescein angiogram, and evaluated the effect of full coverage laser treatment.
Choroid/*blood supply
;
Female
;
Fluorescein Angiography/*methods
;
Fundus Oculi
;
Humans
;
Indocyanine Green/*diagnostic use
;
*Laser Coagulation
;
Macular Degeneration/*complications
;
Male
;
Middle Aged
;
Neovascularization, Pathologic/diagnosis/etiology/*surgery
;
Retinal Hemorrhage/complications
;
Signal Processing, Computer-Assisted
;
Visual Acuity
4.Time-Lag between Subretinal Fluid and Pigment Epithelial Detachment Reduction after Polypoidal Choroidal Vasculopathy Treatment.
Ju Byung CHAE ; Joo Yong LEE ; Sung Jae YANG ; June Gone KIM ; Young Hee YOON
Korean Journal of Ophthalmology 2011;25(2):98-104
PURPOSE: The goal of the present research was to study post-treatment changes in polypoidal choroidal vasculopathy (PCV) shown by optical coherence tomography (OCT). METHODS: The study included 12 patients with naive PCV. Photodynamic therapy and 3 consecutive intravitreal bevacizumab injections at 6-week intervals were given. Best corrected visual acuity, subretinal fluid (SRF), pigment epithelium detachment (PED), central macular thickness (CMT), and total macular volume (TMV) were measured before and after treatment as assessed by Stratus OCT3. RESULTS: After treatment, the SRF height decreased earlier than the PED height. The SRF diameter decreased with statistical significance. However, the PED diameter did not show a statistically significant improvement, persisting at pre-treatment levels. Both CMT and TMV decreased significantly after treatment. CONCLUSIONS: After PCV treatment, SRF and PED stabilized, as shown by OCT. However, the PED treatment response was both delayed and refractory compared to the SRF response. The small change in post-treatment PED diameter may suggest the possibility of PCV recurrence.
Aged
;
Choroid/*pathology
;
Choroid Diseases
;
Choroidal Neovascularization/diagnosis/*drug therapy
;
Disease Progression
;
Female
;
Fluorescein Angiography
;
Follow-Up Studies
;
Fundus Oculi
;
Humans
;
Male
;
Photochemotherapy/*adverse effects
;
Prognosis
;
Retinal Detachment/diagnosis/*etiology
;
Retinal Pigment Epithelium/*pathology
;
Retrospective Studies
;
*Subretinal Fluid
;
Time Factors
;
Tomography, Optical Coherence
;
Visual Acuity
5.Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
Da Ru Chi MOON ; Dong Kyu LEE ; Soon Hyun KIM ; Yong Sung YOU ; Oh Woong KWON
Korean Journal of Ophthalmology 2015;29(4):226-232
PURPOSE: To report the results of switching treatment to vascular endothelial growth factor (VEGF) Trap-Eye (aflibercept) in neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) refractory to anti-VEGF (ranibizumab and bevacizumab). METHODS: This is a retrospective study involving 32 eyes from 29 patients; 18 were cases of neovascular AMD and 14 were cases of PCV. The best-corrected visual acuity (BCVA) and central macular thickness (CMT) of spectral-domain optical coherence tomography were evaluated. RESULTS: BCVA and CMT improved from 0.58 to 0.55 (p = 0.005) and from 404 to 321 microm (p < 0.001), respectively, after switching to aflibercept. The 14 eyes that received 6 or more aflibercept injections remained stable at 0.81 to 0.81 and 321 to 327 microm (p = 1.0, 0.29), respectively, after 3 aflibercept injections. The 10 eyes that received 3 or more bevacizumab injections after 3 or more aflibercept injections worsened, from 0.44 to 0.47 and from 332 to 346 microm (p = 0.06, 0.05), respectively. The results showed similar improvement of BCVA and CMT in neovascular AMD and PCV. CONCLUSIONS: Aflibercept seems to be effective for improvement and maintenance of BCVA and CMT for neovascular AMD and PCV refractory to anti-VEGF. Switching from aflibercept back to bevacizumab treatment may not be a proper strategy.
Angiogenesis Inhibitors/administration & dosage
;
Bevacizumab/administration & dosage
;
Choroid/*blood supply
;
Choroid Diseases/complications/diagnosis/*drug therapy
;
Dose-Response Relationship, Drug
;
Drug Therapy, Combination
;
Female
;
Follow-Up Studies
;
Humans
;
Intravitreal Injections
;
Male
;
Ranibizumab/administration & dosage
;
Receptors, Vascular Endothelial Growth Factor/*administration & dosage
;
Recombinant Fusion Proteins/*administration & dosage
;
Retinal Neovascularization/complications/diagnosis/*drug therapy
;
Retrospective Studies
;
Tomography, Optical Coherence
;
Treatment Outcome
;
Vascular Endothelial Growth Factor A/*antagonists & inhibitors
;
*Visual Acuity
;
Wet Macular Degeneration/diagnosis/*drug therapy/etiology